Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/Safety of Propionyl L-carnitine in Healthy Chinese Subjects
NCT02786069Phase 1Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of propionyl-L-carnitine in Peripheral Arterial Disease (PAD), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Area Under Curve at 24 hours. Started Jun 2015; status: completed.
02
Drugs
propionyl-L-carnitine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02786069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786069.